1.
Case Rep Hematol
; 2013: 520712, 2013.
Artículo
en Inglés
| MEDLINE
| ID: mdl-24307957
RESUMEN
Primary myelofibrosis (PMF) is a myeloproliferative neoplasm frequently complicated by transfusion dependent anemia. Both anemia and transfusion-dependence are associated with a poor outcome, at least in part because of toxic effects of iron overload (IOL). Iron-chelating therapy (ICT) is increasingly used in order to prevent IOL in this setting. Here, we describe the case of a 73-year-old man affected by PMF and severe transfusion-dependent anemia who experienced a dramatic erythroid response after being treated with deferasirox to prevent IOL.
2.
Br J Haematol
; 144(6): 969-70, 2009 Mar.
Artículo
en Inglés
| MEDLINE
| ID: mdl-19120363